| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | 0.23 | 0.1 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.1 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | 0.073 | 0.2 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.2 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |